Integer Holdings Corporation is a medical device outsource manufacturer serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and power solutions markets.
ITGR Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Integer Holdings Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Integer Holdings Corp ranked in the 42th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 18%. The most interesting components of our discounted cash flow analysis for Integer Holdings Corp ended up being:
The business' balance sheet reveals debt to be 32% of the company's capital (with equity being the remaining amount). Approximately 55.78% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
Integer Holdings Corp's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 2.83. This coverage rate is greater than that of 52.25% of stocks we're observing for the purpose of forecasting via discounted cash flows.
The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than 53.38% of stocks in its sector (Healthcare).
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
FONR, PRAH, AMGN, IART, and CNC can be thought of as valuation peers to ITGR, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Integer Holdings Corporation (ITGR) Q2 2020 Results Earnings Conference Call July 30, 2020, 9:00 am ET Company Participants Tony Borowicz - Senior Vice President of Strategy, Business Development and Investor Relations Joe Dziedzic - President, Chief Executive Officer Jason Garland - Executive Vice President, Chief Financial Officer Conference Call Participants...
PLANO, Texas, July 30, 2020 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended July 3, 2020. Unless otherwise stated, all results and comparisons are from continuing operations. Leading through the “new normal” of COVID-19 * COVID-19 safety measures are in place for Integer associates, who continue to deliver critical products that customers and patients rely on every day. * Integer is treating the current environment as the “new normal” by increasing its agility to respond to changing customer demand and adjusting costs related to the expected temporary volume decline. * Integer continues to execute its operational strategic imperatives to create long-term value. * Integ...